— Know what they know.
Not Investment Advice

PFHO OTC

Pacific Health Care Organization, Inc.
1W: -6.0% 1M: -8.7% 3M: +10.6% YTD: -27.7% 1Y: -19.7% 3Y: +9.3% 5Y: +1.0%
$0.94
+0.00 (+0.32%)
 
Weekly Expected Move ±7.8%
$1 $1 $1 $1 $1
OTC · Healthcare · Medical - Healthcare Plans · Tech Score Sell · Power 38 · $12.0M mcap · 3M float · 0.459% daily turnover · Short 55% of daily vol

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

A-
Oct 02, 2026
DCF
5
ROE
3
ROA
5
D/E
1
P/E
3
P/B
4
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. PFHO receives an overall rating of A-. Strongest factors: DCF (5/5), ROA (5/5), P/B (4/5). Areas of concern: D/E (1/5).
Rating Change History
DateFromTo
2026-10-01 B+ A-
2026-09-29 A- B+
2026-09-25 B+ A-
2026-09-21 A- B+
2026-09-08 B+ A-
2026-08-17 A- B+
2026-05-27 None ADDED
2026-05-26 EXISTED None
2026-05-21 None ADDED
2026-05-10 EXISTED None

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 45 Grade B
Profitability
55
Balance Sheet
92
Earnings Quality
56
Growth
19
Value
76
Momentum
33
Safety
100
Cash Flow
43
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. PFHO scores highest in Safety (100/100) and lowest in Growth (19/100). A grade of B indicates above-average fundamentals with room for improvement in select areas.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
15.82
Safe Zone
Piotroski F-Score
4/9
✓ ✓ ✗ ✗ ✗ ✓ ✓ ✗ ✗
Beneish M-Score
-1.65
Possible Manipulator
Ohlson O-Score
-11.36
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
AA
Score: 89.0/100
Trend: Stable
Earnings Quality
50/100
OCF/NI: 0.61x
Accruals: 2.8%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. PFHO scores 15.82, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. PFHO scores 4/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. PFHO's score of -1.65 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. PFHO's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. PFHO receives an estimated rating of AA (score: 89.0/100), with a stable trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). PFHO's score of 50/100 is moderate — some divergence between reported earnings and underlying cash flows.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
12.29x
PEG
-0.40x
P/S
1.87x
P/B
0.88x
P/FCF
19.11x
P/OCF
18.22x
EV/EBITDA
-1.50x
EV/Revenue
-0.24x
EV/EBIT
-1.53x
EV/FCF
-2.77x
Earnings Yield
8.98%
FCF Yield
5.23%
Shareholder Yield
0.00%
Graham Number
$1.35
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 12.3x earnings, PFHO trades at a reasonable valuation. An earnings yield of 9.0% exceeds typical risk-free rates, suggesting equities are being compensated for risk. Graham's intrinsic value formula yields $1.35 per share, suggesting a potential 44% margin of safety at the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.739
NI / EBT
×
Interest Burden
1.285
EBT / EBIT
×
EBIT Margin
0.160
EBIT / Rev
×
Asset Turnover
0.470
Rev / Assets
×
Equity Multiplier
1.046
Assets / Equity
=
ROE
7.5%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. PFHO's ROE of 7.5% is driven by Asset Turnover (0.470), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
15.00%
Fair P/E
38.50x
Intrinsic Value
$2.94
Price/Value
0.29x
Margin of Safety
71.09%
Premium
-71.09%
Assessment
Neutral
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with PFHO's realized 15.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. PFHO actually compounded EPS at 26.2% over three years; the model uses 15%, the highest rate it will extrapolate — of 4,457 company-quarters that grew faster than 200%, none sustained it over the following seven years. PFHO trades at a -71% premium to its adjusted intrinsic value of $2.94, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 38.5x compares to the current market P/E of 12.3x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$0.94
Median 1Y
$0.26
5th Pctile
$0.02
95th Pctile
$3.22
Ann. Volatility
159.1%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Donald Balzano CEO,
er CEO, Medex Healthcare
$125,875 $— $164,717
Doug Hikawa President,
Medex
$137,908 $— $148,168
Healthcare Geri Plotzke
Vice President, Medex Healthcare
$92,800 $— $134,243
Tom Kubota
President and Director
$71,400 $— $71,400

CEO Pay Ratio

2:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $164,717
Avg Employee Cost (SGA/emp): $73,923
Employees: 30

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
30
+3.5% YoY
Revenue / Employee
$223,839
Rev: $6,715,175
Profit / Employee
$46,255
NI: $1,387,647
SGA / Employee
$73,923
Avg labor cost proxy

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE 8.6% 9.6% 6.3% 6.5% 7.5% 4.5% 3.9% 4.5% 4.3% 6.9% 7.4% 8.1% 7.9% 7.9% 8.5% 11.7% 12.0% 11.2% 10.2% 7.5% 7.47%
ROA 7.8% 8.9% 5.9% 6.2% 7.1% 4.2% 3.7% 4.3% 4.1% 6.4% 6.9% 7.6% 7.4% 7.3% 7.9% 11.1% 11.4% 10.7% 9.8% 7.1% 7.14%
ROIC 71.8% 53.1% 1.1% 73.8% 94.9% 84.6% 56.4% 90.9% 66.1% 1.1% 2.4% 1.1% 88.2% 96.4% 7.2% 1.1% 99.4% 84.9% 85.9% 60.8% 60.82%
ROCE 10.6% 4.8% 1.8% 2.1% 3.5% 6.1% 5.3% 6.6% 5.4% 8.1% 8.8% 8.2% 8.1% 9.1% 10.0% 15.1% 16.0% 13.7% 11.7% 7.6% 7.58%
Gross Margin 34.4% 43.5% 41.5% 36.8% 36.6% 37.1% 31.0% 33.2% 35.7% 47.0% 34.8% 40.6% 35.5% 47.7% 50.2% 1.0% 45.0% 47.9% 43.0% 48.7% 48.74%
Operating Margin 8.2% 11.0% 18.4% 12.4% 18.4% -0.6% 6.3% 11.2% 10.7% 18.5% 12.5% 12.2% 9.9% 21.7% 17.3% 17.6% 12.9% 11.2% 11.5% 20.8% 20.82%
Net Margin 5.9% 22.2% 13.2% 8.9% 13.2% -0.8% 10.0% 13.6% 13.0% 17.1% 14.1% 13.7% 11.4% 19.2% 16.1% 36.9% 14.1% 14.9% 12.9% 18.4% 18.43%
EBITDA Margin 9.1% -20.6% 18.7% 13.0% 19.0% 0.1% 14.6% 19.6% 11.3% 19.1% 20.3% 12.8% 10.5% 29.6% 17.3% 52.2% 19.9% 11.6% 11.9% 21.1% 21.11%
FCF Margin 13.0% 6.8% 7.4% 5.5% 8.5% 11.7% 3.2% 11.1% 10.0% 16.2% 21.8% 14.9% 10.7% 11.0% 10.9% 18.1% 19.3% 16.8% 16.2% 8.8% 8.85%
OCF Margin 13.2% 7.2% 7.8% 6.1% 8.9% 12.4% 3.7% 11.5% 10.5% 16.6% 22.1% 15.3% 11.1% 11.2% 11.1% 18.3% 19.6% 17.3% 16.5% 9.3% 9.28%
ROE 3Y Avg snapshot only 8.69%
ROE 5Y Avg snapshot only 7.43%
ROA 3Y Avg snapshot only 8.25%
ROIC Economic snapshot only 5.08%
Cash ROA snapshot only 4.24%
Cash ROIC snapshot only 53.16%
CROIC snapshot only 50.69%
NOPAT Margin snapshot only 10.62%
Pretax Margin snapshot only 20.55%
R&D / Revenue snapshot only 0.00%
SGA / Revenue snapshot only 26.86%
SBC / Revenue snapshot only 0.00%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio 11.84 10.95 13.56 14.62 11.59 17.66 24.49 23.40 22.96 11.83 10.14 12.91 12.24 10.44 9.43 7.32 10.35 11.99 11.93 11.13 12.288
P/S Ratio 1.83 2.02 1.67 1.86 1.67 1.52 1.89 2.06 2.00 1.61 1.48 1.88 1.73 1.53 1.43 1.55 2.25 2.48 2.41 1.69 1.868
P/B Ratio 0.97 1.01 0.83 0.93 0.84 0.77 0.93 1.10 1.04 0.84 0.77 1.01 0.93 0.79 0.77 0.81 1.17 1.27 1.16 0.80 0.885
P/FCF 14.10 29.60 22.38 33.50 19.63 12.95 60.07 18.57 19.99 9.93 6.80 12.62 16.17 13.85 13.16 8.55 11.65 14.74 14.86 19.11 19.114
P/OCF 13.85 28.19 21.27 30.52 18.71 12.24 50.67 17.89 19.10 9.75 6.69 12.32 15.67 13.66 12.91 8.46 11.47 14.34 14.53 18.22 18.225
EV/EBITDA 0.35 1.55 -5.83 -0.32 -2.60 -2.79 -0.21 1.99 1.26 -1.42 -2.29 0.60 -0.11 -1.68 6.07 -0.89 1.50 2.58 1.80 -1.50 -1.500
EV/Revenue 0.07 0.16 -0.25 -0.02 -0.20 -0.35 -0.02 0.26 0.14 -0.23 -0.40 0.10 -0.02 -0.31 1.06 -0.25 0.45 0.66 0.44 -0.24 -0.245
EV/EBIT 0.36 1.70 -7.05 -0.38 -2.84 -2.93 -0.22 2.10 1.35 -1.48 -2.38 0.63 -0.12 -1.73 5.73 -0.86 1.45 2.48 1.83 -1.53 -1.531
EV/FCF 0.56 2.39 -3.33 -0.29 -2.31 -3.02 -0.77 2.35 1.40 -1.42 -1.86 0.64 -0.16 -2.77 9.80 -1.36 2.32 3.92 2.75 -2.77 -2.768
Earnings Yield 8.4% 9.1% 7.4% 6.8% 8.6% 5.7% 4.1% 4.3% 4.4% 8.4% 9.9% 7.7% 8.2% 9.6% 10.6% 13.7% 9.7% 8.3% 8.4% 9.0% 8.98%
FCF Yield 7.1% 3.4% 4.5% 3.0% 5.1% 7.7% 1.7% 5.4% 5.0% 10.1% 14.7% 7.9% 6.2% 7.2% 7.6% 11.7% 8.6% 6.8% 6.7% 5.2% 5.23%
Price/Tangible Book snapshot only 0.801
EV/OCF snapshot only -2.639
EV/Gross Profit snapshot only -0.529
Acquirers Multiple snapshot only -1.705
Shareholder Yield snapshot only 0.00%
Graham Number snapshot only $1.35
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 18.62 22.23 18.76 22.71 27.68 16.78 17.77 13.85 14.47 11.59 11.60 16.35 16.15 16.54 18.55 18.93 29.17 34.45 27.58 27.21 27.208
Quick Ratio 18.63 22.27 18.76 22.71 27.68 16.79 17.77 13.85 14.47 11.59 11.60 16.35 16.15 16.54 18.55 18.93 29.17 34.45 27.58 27.21 27.208
Debt/Equity 0.03 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Net Debt/Equity -0.93 -0.93 -0.96 -0.93 -0.94 -0.95 -0.94 -0.96 -0.96 -0.96 -0.98 -0.95 -0.94 -0.95 -0.20 -0.94 -0.94 -0.93 -0.94 -0.92 -0.917
Debt/Assets 0.03 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Debt/EBITDA 0.30 0.12 0.00 0.00 0.00 0.07 0.06 0.00 0.00 0.06 0.05 0.00 0.00 0.03 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Net Debt/EBITDA -8.31 -17.71 -45.02 -37.97 -24.67 -14.76 -16.55 -13.75 -16.76 -11.34 -10.68 -11.21 -11.21 -10.05 -2.08 -6.49 -6.04 -7.12 -7.94 -11.86 -11.861
Interest Coverage 307.63 99.61 129.16 156.81 263.61 — — — — — — — — 300.56 236.16 374.84 406.08 1175.38 — — —
Equity Multiplier 1.07 1.05 1.06 1.05 1.04 1.06 1.06 1.08 1.08 1.09 1.09 1.06 1.07 1.06 1.06 1.06 1.04 1.03 1.04 1.04 1.038
Cash Ratio snapshot only 24.167
Defensive Interval snapshot only 2453.0 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.50 0.48 0.48 0.49 0.50 0.49 0.47 0.48 0.47 0.47 0.47 0.52 0.52 0.50 0.52 0.52 0.52 0.52 0.48 0.47 0.470
Inventory Turnover — — — — — — — — — — — — — — — — — — — — —
Receivables Turnover 6.17 5.43 6.70 6.72 6.92 6.17 6.26 6.14 6.42 5.76 6.09 6.63 6.37 5.89 7.13 6.51 6.32 6.60 6.40 5.32 5.319
Payables Turnover 65.21 54.26 42.03 48.32 46.47 23.13 25.12 38.70 33.87 16.69 18.83 29.57 24.92 23.62 19.78 17.31 14.00 13.84 11.80 18.18 18.176
DSO 59 67 55 54 53 59 58 59 57 63 60 55 57 62 51 56 58 55 57 69 68.6 days
DIO -0 -1 0 0 -0 -1 0 0 0 -0 0 0 0 0 0 0 0 0 0 0 0.0 days
DPO 6 7 9 8 8 16 15 9 11 22 19 12 15 15 18 21 26 26 31 20 20.1 days
Cash Conversion Cycle 53 59 46 47 45 42 44 50 46 41 41 43 43 47 33 35 32 29 26 49 48.5 days
Fixed Asset Turnover snapshot only 142.309
Cash Velocity snapshot only 0.517
Capital Intensity snapshot only 2.190
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue -11.7% -10.6% -5.3% -2.2% 2.2% 6.3% 2.3% -0.6% -4.5% -2.0% 1.5% 8.3% 12.6% 7.2% 13.0% 10.5% 8.7% 11.2% -1.0% -2.6% -2.60%
Net Income 32.6% 81.1% -27.6% -23.4% -4.7% -50.5% -35.6% -31.0% -42.2% 55.8% 91.6% 79.2% 83.2% 15.1% 17.3% 60.3% 66.6% 57.0% 31.7% -30.1% -30.10%
EPS 32.6% 81.1% -27.6% -23.4% -4.7% -50.4% -35.6% -31.0% -42.2% 55.8% 91.6% 79.2% 83.2% 14.9% 17.3% 60.3% 66.6% 57.2% 31.7% -30.1% -30.10%
FCF 11.2% -60.6% -57.3% -66.3% -33.0% 82.7% -56.7% 99.5% 12.4% 36.1% 6.0% 45.4% 20.7% -27.2% -43.6% 34.3% 95.7% 69.5% 47.6% -52.5% -52.49%
EBITDA 19.6% -35.4% -81.8% -78.3% -63.4% 28.6% 1.8% 1.6% 40.1% 25.9% 54.5% 31.7% 58.7% 20.3% 12.3% 92.0% 1.1% 55.7% 39.4% -42.6% -42.63%
Op. Income -27.0% -37.0% -14.5% -7.1% 28.4% 34.2% -21.9% -30.6% -57.4% -2.1% 50.1% 68.5% 1.2% 25.7% 28.6% 34.9% 40.6% 17.4% -13.4% -16.2% -16.16%
OCF Growth snapshot only -50.66%
Asset Growth snapshot only 5.98%
Equity Growth snapshot only 7.76%
Shares Change snapshot only 0.00%
Dividend Growth snapshot only -1.00%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y -5.5% -7.4% -7.7% -8.0% -7.9% -7.8% -7.4% -6.4% -4.9% -2.3% -0.6% 1.7% 3.2% 3.8% 5.5% 5.9% 5.4% 5.3% 4.3% 5.2% 5.23%
Revenue 5Y 0.2% -1.0% -1.4% -2.6% -2.6% -2.5% -3.0% -3.3% -3.8% -3.7% -4.0% -3.5% -3.4% -3.8% -1.9% -0.4% 1.1% 2.1% 1.9% 2.5% 2.51%
EPS 3Y -12.8% -9.9% -19.0% -16.2% -12.7% -25.6% -24.4% -17.4% -9.9% 11.8% -3.7% -1.8% 0.3% -3.9% 13.1% 25.6% 20.8% 41.2% 43.6% 26.2% 26.17%
EPS 5Y -19.3% -15.2% -24.6% -27.1% -26.0% -33.7% -15.9% -16.9% -18.3% -10.8% -8.1% -6.1% -6.8% -5.9% -0.6% 10.1% 17.4% 20.4% 6.7% 1.2% 1.21%
Net Income 3Y -12.8% -9.9% -19.0% -16.2% -12.7% -25.6% -24.4% -17.4% -9.9% 11.8% -3.7% -1.8% 0.3% -3.9% 13.1% 25.6% 20.8% 41.2% 43.6% 26.2% 26.17%
Net Income 5Y 6.5% 11.9% -0.5% -3.8% -2.3% -12.6% -17.5% -16.9% -18.3% -10.8% -8.1% -6.1% -6.8% -5.9% -0.6% 10.1% 17.4% 20.4% 6.7% 1.2% 1.21%
EBITDA 3Y -16.0% -33.9% -49.7% -45.9% -37.7% -25.5% -24.0% -17.4% -15.0% 1.5% -7.8% -8.9% -6.6% 24.9% 69.1% 88.4% 66.4% 33.1% 34.2% 13.2% 13.20%
EBITDA 5Y 1.1% -11.7% -28.7% -29.3% -23.6% -16.2% -19.5% -18.1% -21.2% -14.1% -11.3% -11.3% -11.7% -8.9% -5.3% 7.3% 15.1% 14.4% 4.2% -3.6% -3.61%
Gross Profit 3Y -21.1% -20.9% -17.8% -16.0% -14.1% -14.9% -15.5% -13.8% -11.1% -5.5% -1.6% 1.9% 5.0% 6.1% 9.7% 21.6% 21.9% 23.5% 24.4% 15.9% 15.93%
Gross Profit 5Y -3.0% -9.3% -9.3% -11.5% -11.6% -12.3% -14.4% -15.0% -15.2% -12.4% -10.8% -8.2% -7.3% -7.5% -3.1% 5.5% 9.0% 10.5% 10.9% 5.8% 5.76%
Op. Income 3Y -29.7% -35.1% -28.1% -25.1% -20.5% -25.6% -28.6% -26.4% -26.4% -6.1% 0.1% 2.8% 7.1% 18.2% 14.7% 16.4% 10.4% 13.0% 18.7% 24.0% 23.96%
Op. Income 5Y -8.2% -11.8% -11.1% -13.8% -11.5% -16.3% -22.7% -23.9% -28.3% -18.5% -15.3% -13.2% -13.6% -12.7% -6.8% -1.9% 4.7% 4.1% 2.2% 4.2% 4.20%
FCF 3Y -16.7% -34.0% -15.6% -32.7% -27.2% -13.3% -45.9% -13.6% -5.7% -0.7% 9.0% -0.8% -3.1% 21.9% 19.6% 57.3% 38.5% 18.9% 80.0% -2.5% -2.47%
FCF 5Y -15.1% -20.6% -8.9% -20.3% -8.5% -3.6% -35.7% -11.5% -15.3% -6.5% 12.8% -2.4% -12.1% -8.4% -9.0% 4.7% 14.6% 3.9% 1.5% -9.0% -9.03%
OCF 3Y -16.9% -33.6% -15.8% -31.5% -27.1% -13.3% -44.0% -15.1% -7.3% -1.9% 8.2% -0.6% -2.7% 20.4% 18.4% 53.0% 37.0% 17.7% 71.3% -2.1% -2.13%
OCF 5Y -15.8% -20.4% -9.1% -19.5% -8.1% -3.0% -33.6% -11.1% -15.0% -6.7% 11.8% -2.8% -12.4% -9.2% -9.8% 3.1% 12.8% 3.3% 1.2% -8.5% -8.49%
Assets 3Y 11.0% 10.0% 6.3% 6.1% 5.1% 5.5% 5.1% 1.1% 1.3% 2.1% 2.4% 2.0% 2.5% 3.1% 2.9% 4.5% 4.2% 3.8% 4.2% 8.1% 8.14%
Assets 5Y 13.4% 12.6% 11.9% 11.2% 11.1% 10.7% 9.4% 7.1% 6.5% 6.8% 4.4% 4.1% 3.7% 3.9% 3.9% 4.3% 4.0% 3.9% 4.2% 4.6% 4.63%
Equity 3Y 10.6% 10.2% 9.5% 8.8% 8.0% 6.8% 6.8% 2.8% 2.9% 3.2% 2.1% 2.4% 2.7% 2.6% 2.8% 4.2% 4.3% 4.9% 5.0% 9.5% 9.54%
Book Value 3Y 10.6% 10.2% 9.5% 8.8% 8.0% 6.8% 6.8% 2.8% 2.9% 3.2% 2.1% 2.4% 2.7% 2.6% 2.8% 4.2% 4.3% 4.9% 5.0% 9.5% 9.54%
Dividend 3Y — — — — — — — — — — — -53.4% -71.3% -77.3% — -82.3% -23.6% -64.7% — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.01 0.02 0.09 0.35 0.44 0.42 0.54 0.69 0.87 0.71 0.67 0.49 0.42 0.39 0.16 0.01 0.05 0.25 0.52 0.67 0.670
Earnings Stability 0.00 0.01 0.05 0.27 0.26 0.40 0.87 0.92 0.73 0.50 0.60 0.45 0.25 0.08 0.03 0.17 0.36 0.46 0.32 0.23 0.233
Margin Stability 0.78 0.80 0.81 0.79 0.77 0.75 0.73 0.72 0.72 0.77 0.81 0.85 0.87 0.88 0.89 0.78 0.76 0.77 0.77 0.78 0.783
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.00 0.00 0.00 1.00 0.50 0.50 0.50 1.00 1.00 1.00 1.00 0.00 0.00 0.000
Earn. Growth Consistency 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.87 0.50 0.89 0.91 0.98 0.50 0.86 0.88 0.83 0.50 0.50 0.50 0.50 0.94 0.93 0.50 0.50 0.50 0.87 0.88 0.880
Earnings Smoothness 0.72 0.42 0.68 0.73 0.95 0.33 0.57 0.63 0.46 0.56 0.37 0.43 0.41 0.86 0.84 0.54 0.50 0.56 0.73 0.65 0.646
ROE Trend -0.02 -0.00 -0.04 -0.03 -0.00 -0.03 -0.04 -0.03 -0.03 0.00 0.03 0.02 0.02 0.02 0.02 0.05 0.05 0.03 0.02 -0.02 -0.022
Gross Margin Trend -0.08 -0.08 -0.04 -0.03 -0.00 -0.01 -0.04 -0.05 -0.04 -0.00 0.01 0.03 0.03 0.02 0.07 0.22 0.24 0.23 0.19 -0.03 -0.033
FCF Margin Trend -0.01 -0.08 -0.09 -0.10 -0.03 0.01 -0.09 0.00 -0.01 0.07 0.16 0.07 0.01 -0.03 -0.02 0.05 0.09 0.03 -0.00 -0.08 -0.077
Sustainable Growth Rate 8.6% 9.6% 6.3% 6.5% 7.5% 4.5% 3.9% -5.8% -6.7% -4.0% -3.5% 7.1% 7.7% 7.7% 8.5% 11.7% 11.8% 11.2% 10.2% 7.5% 7.47%
Internal Growth Rate 8.4% 9.7% 6.3% 6.6% 7.7% 4.4% 3.8% — — — — 7.0% 7.7% 7.7% 8.6% 12.5% 12.7% 12.0% 10.8% 7.7% 7.69%
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 0.86 0.39 0.64 0.48 0.62 1.44 0.48 1.31 1.20 1.21 1.52 1.05 0.78 0.76 0.73 0.87 0.90 0.84 0.82 0.61 0.611
FCF/OCF 0.98 0.95 0.95 0.91 0.95 0.95 0.84 0.96 0.96 0.98 0.98 0.98 0.97 0.99 0.98 0.99 0.99 0.97 0.98 0.95 0.953
FCF/Net Income snapshot only 0.582
OCF/EBITDA snapshot only 0.568
CapEx/Revenue 0.2% 0.3% 0.4% 0.5% 0.4% 0.7% 0.6% 0.4% 0.5% 0.3% 0.4% 0.4% 0.3% 0.2% 0.2% 0.2% 0.3% 0.5% 0.4% 0.4% 0.43%
CapEx/Depreciation snapshot only 1.308
Accruals Ratio 0.01 0.05 0.02 0.03 0.03 -0.02 0.02 -0.01 -0.01 -0.01 -0.04 -0.00 0.02 0.02 0.02 0.01 0.01 0.02 0.02 0.03 0.028
Sloan Accruals snapshot only 0.072
Cash Flow Adequacy snapshot only 21.498
Earnings Quality Score snapshot only 0.500
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 9.7% 11.1% 13.3% 14.5% 1.0% 0.3% 0.2% 0.0% 0.0% 0.1% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.09 $0.09 $0.09 $0.10 $0.01 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 2.3% 2.5% 1.6% 1.5% 12.9% 3.3% 1.6% 0.0% 0.0% 0.9% 0.0% 0.0% 0.0% 0.00%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 1.8% 2.2% 1.3% 98.4% 12.6% 4.4% 2.1% 0.0% 0.1% 1.0% 0.1% 0.1% 0.0% 0.00%
Total Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 2.3% 2.5% 1.6% 1.5% 12.9% 3.3% 1.6% 0.0% 0.0% 0.9% 0.0% 0.0% 0.0% 0.00%
Div. Increase Streak — — — — — — — 0 0 0 0 0 0 0 — 0 0 0 0 — —
Chowder Number — — — — — — — — — — — -0.89 -0.97 -0.99 — -0.99 -0.55 -0.96 — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Shareholder Return 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 9.7% 11.1% 13.3% 14.5% 1.0% 0.3% 0.2% 0.0% 0.0% 0.1% 0.0% 0.0% 0.0% 0.00%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 0.76 0.83 0.77 0.77 0.76 0.71 0.71 0.71 0.71 0.71 0.71 0.71 0.69 0.70 0.70 0.70 0.71 0.73 0.73 0.74 0.739
Interest Burden (EBT/EBIT) 1.00 2.32 4.53 3.91 2.73 1.00 1.00 1.00 1.18 1.24 1.22 1.35 1.36 1.18 1.16 1.05 0.99 1.06 1.13 1.29 1.285
EBIT Margin 0.20 0.10 0.04 0.04 0.07 0.12 0.11 0.12 0.10 0.16 0.17 0.15 0.15 0.18 0.19 0.29 0.31 0.27 0.24 0.16 0.160
Asset Turnover 0.50 0.48 0.48 0.49 0.50 0.49 0.47 0.48 0.47 0.47 0.47 0.52 0.52 0.50 0.52 0.52 0.52 0.52 0.48 0.47 0.470
Equity Multiplier 1.10 1.09 1.07 1.06 1.06 1.06 1.06 1.06 1.06 1.08 1.08 1.07 1.07 1.08 1.07 1.06 1.05 1.05 1.05 1.05 1.046
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $0.07 $0.08 $0.05 $0.06 $0.06 $0.04 $0.03 $0.04 $0.04 $0.06 $0.07 $0.07 $0.07 $0.07 $0.08 $0.11 $0.11 $0.11 $0.10 $0.08 $0.08
Book Value/Share $0.82 $0.84 $0.86 $0.87 $0.88 $0.88 $0.89 $0.81 $0.82 $0.84 $0.86 $0.88 $0.89 $0.91 $0.93 $0.98 $1.00 $1.02 $1.04 $1.06 $1.06
Tangible Book/Share $0.82 $0.84 $0.86 $0.87 $0.88 $0.88 $0.89 $0.81 $0.82 $0.84 $0.86 $0.88 $0.89 $0.91 $0.93 $0.98 $1.00 $1.02 $1.04 $1.06 $1.06
Revenue/Share $0.44 $0.42 $0.43 $0.43 $0.45 $0.45 $0.44 $0.43 $0.43 $0.44 $0.45 $0.47 $0.48 $0.47 $0.50 $0.52 $0.52 $0.52 $0.50 $0.50 $0.50
FCF/Share $0.06 $0.03 $0.03 $0.02 $0.04 $0.05 $0.01 $0.05 $0.04 $0.07 $0.10 $0.07 $0.05 $0.05 $0.05 $0.09 $0.10 $0.09 $0.08 $0.04 $0.04
OCF/Share $0.06 $0.03 $0.03 $0.03 $0.04 $0.06 $0.02 $0.05 $0.04 $0.07 $0.10 $0.07 $0.05 $0.05 $0.06 $0.09 $0.10 $0.09 $0.08 $0.05 $0.05
Cash/Share $0.79 $0.79 $0.82 $0.81 $0.83 $0.84 $0.85 $0.78 $0.79 $0.82 $0.84 $0.84 $0.84 $0.87 $0.18 $0.93 $0.94 $0.95 $0.98 $0.97 $0.97
EBITDA/Share $0.09 $0.04 $0.02 $0.02 $0.03 $0.06 $0.05 $0.06 $0.05 $0.07 $0.08 $0.07 $0.07 $0.09 $0.09 $0.14 $0.16 $0.13 $0.12 $0.08 $0.08
Debt/Share $0.03 $0.01 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Net Debt/Share $-0.76 $-0.78 $-0.82 $-0.81 $-0.83 $-0.84 $-0.84 $-0.78 $-0.79 $-0.81 $-0.84 $-0.84 $-0.84 $-0.86 $-0.18 $-0.93 $-0.94 $-0.95 $-0.98 $-0.97 $-0.97
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 15.820
Altman Z-Prime snapshot only 31.985
Piotroski F-Score 6 6 6 6 7 6 4 5 4 6 7 8 6 7 8 7 7 8 5 4 4
Beneish M-Score -2.55 -2.33 -2.34 -1.98 -2.58 -2.81 -2.34 -2.86 -2.37 -2.42 -2.70 -2.40 -2.67 -0.60 -0.36 -0.73 -1.60 -2.40 -2.31 -1.65 -1.650
Ohlson O-Score snapshot only -11.359
ROIC (Greenblatt) snapshot only 7.59%
Net-Net WC snapshot only $1.06
EVA snapshot only $571474.48
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only AA
Credit Score 96.64 96.70 89.00 89.00 89.00 94.93 94.81 89.00 89.00 94.66 94.56 89.00 89.00 97.73 89.00 89.00 89.00 89.00 89.00 89.00 89.000
Credit Grade snapshot only 3
Credit Trend snapshot only 0.000
Implied Spread (bps) snapshot only 80.000
Industry Credit Rank snapshot only 94
Sector Credit Rank snapshot only 88

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms